Evaluating Bioequivalence of a Fixed Dose Combination versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin.
This study is looking at a new combination pill designed to help manage cholesterol. It contains two medicines, bempedoic acid and ezetimibe, along with rosuvastatin, which are all used to lower cholesterol. Researchers want to see if taking these medicines together in one pill works in the human body in the exact same way as taking each medicine separately. This is an early-stage study involving healthy adults. It's an important step to ensure that the combined pill will be effective and safe before it can be considered for wider use.
At a glance
What is this study about?
Imagine you need to take a few different medicines every day. Wouldn't it be easier if you could take just one pill that contained all of them? That's the basic idea behind this study. Researchers have created a new pill that combines three different medicines that are used to help lower cholesterol: bempedoic acid, ezetimibe, and rosuvastatin.
This study is designed to answer a very important question: does this new combined pill work in the body in exactly the same way as taking individual tablets of each medicine? This is called 'bioequivalence'. It doesn't mean they are testing if the medicines *work* to lower cholesterol – that's already known. Instead, it's about making sure the new combined pill releases the medicines into your bloodstream at the same speed and in the same amounts as the separate pills.
This kind of research is a crucial early step in developing new medications. By ensuring the combined pill acts the same way as the individual ones, scientists can be confident that it will have the same helpful effects for patients. If the study shows they are equivalent, it could mean a more convenient way for people to take their cholesterol-lowering medication in the future.
Key takeaways
- It's about a new combined pill for cholesterol.
- The study checks if it works the same as separate pills.
- It's for healthy adults, aged 18 and over.
- Your contribution helps develop future medicines.
- Participation involves clinic stays and health checks.
Who may be eligible?
This study is looking for healthy adults to take part. This means you shouldn't have any major ongoing medical conditions or be taking lots of other medicines.
To join, you need to be at least 18 years old. There's no upper age limit, meaning older adults can also take part. Both men and women are welcome.
The research team will carry out some checks to make sure you're healthy enough and that the study is suitable for you. They will explain everything clearly before you decide to participate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you generally healthy?
- Are you 18 years old or older?
- Are you willing to stay at a research clinic for periods?
- Are you able to follow study instructions carefully?
What does participation involve?
Taking part in this study means you would be staying at a special clinic for a few periods. You'll be given the study medication – either the new combined pill or the separate tablets – and the doctors will closely monitor how your body reacts. This usually involves regular blood samples to check how the medicines are absorbed. You might also have physical examinations and other health checks too. The study will happen over some time, and you'll have follow-up visits after you leave the clinic to make sure you're doing well. The total time you're involved will be fully explained by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What does 'bioequivalence' mean?
It means the study is checking if the combined pill releases the medicines into your body in the exact same way and at the same speed as taking two separate pills.
Do I need to have high cholesterol to join?
No, this study is looking for healthy adults without any listed medical conditions.
Will I know if I'm taking the new pill or the old pills?
The study team will explain how and when you'll be given the different medications as part of the study design.
How long will I have to stay in the clinic?
The study team will give you a detailed schedule of clinic stays and follow-up visits when you inquire about participation.
What happens after the study is finished?
After you complete all visits, the study team will let you know you've finished. Your participation contributes to important research.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.